Cara Therapeutics - Stock Price History | CARA

Historical daily share price chart and data for Cara Therapeutics since 2021 adjusted for splits. The latest closing stock price for Cara Therapeutics as of October 15, 2021 is 13.16.
  • The all-time high Cara Therapeutics stock closing price was 29.19 on April 09, 2021.
  • The Cara Therapeutics 52-week high stock price is 29.65, which is 125.3% above the current share price.
  • The Cara Therapeutics 52-week low stock price is 11.22, which is 14.7% below the current share price.
  • The average Cara Therapeutics stock price for the last 52 weeks is 16.28.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Cara Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 15.2844 15.4400 17.9200 9.1200 15.1300 -6.08%
2019 19.7191 14.5600 26.9100 14.4100 16.1100 23.92%
2018 16.4059 12.8400 23.9500 11.6000 13.0000 6.21%
2017 14.7592 9.7600 26.9500 9.7600 12.2400 31.75%
2016 7.3018 16.6900 17.5400 4.4700 9.2900 -44.90%
2015 13.8241 10.6000 22.9200 9.3000 16.8600 69.11%
2014 12.5804 12.9100 22.4900 7.7600 9.9700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.659B $0.135B
Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00